Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09PTY
|
|||
| Former ID |
DIB012234
|
|||
| Drug Name |
V-212
|
|||
| Synonyms |
Heat-treated varicella zoster virus vaccine (herpes zoster), Merck & Co
Click to Show/Hide
|
|||
| Indication | Varicella zoster virus infection [ICD-11: 1E91] | Phase 3 | [1] | |
| Zoster [ICD-11: 1E91; ICD-10: B02; ICD-9: 53] | Phase 3 | [2], [3] | ||
| Company |
Merck & Co Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01254630) A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.